Targeting EGFR and ALK mutations
21 Jul 2017
Targeting EGFR and ALK mutations
The Bonnie J Addario Lung Cancer Foundation
iManageCancer: Data mining and analysis
iManageCancer: Mobile data collection to track patient wellbeing
New drugs on the horizon for pancreatic cancer
Recommendations for surveillance of adenomas
New evolutions for the neoadjuvant and adjuvant treatment of oesophageal cancer
Do variations in prognostic risk stratification criteria for patients with gastrointestinal stromal tumours affect adjuvant treatment?
Cholangiocarcinoma and gallbladder cancer
Left versus right in colon cancer
The GI oncologist of the future
Minimally invasive surgery for cancer of the oesophagus